Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 8 (6), 695-702

Ability of Different Rescue Therapies to Save the Bowel in Acute, Severe, Steroid-Refractory Ulcerative Colitis

Affiliations
Review

Ability of Different Rescue Therapies to Save the Bowel in Acute, Severe, Steroid-Refractory Ulcerative Colitis

Klaudia Farkas et al. Expert Rev Gastroenterol Hepatol.

Abstract

To date, corticosteroids have been the primary therapies for acute, severe ulcerative colitis (UC). Patients not responding to intravenous steroids assessed at 3-5 days of the treatment are candidates for second-line rescue therapy. Cyclosporine (CsA), tacrolimus and infliximab (IFX) are also effective therapeutic options in acute, severe UC. In this review we summarized the results of the published studies examining and comparing the efficacy of CsA, tacrolimus and IFX as rescue therapies, and assessing the outcome of switching the drugs in case of therapeutic failure.

Keywords: acute ulcerative colitis; cyclosporine; infliximab; rescue therapy; tacrolimus.

Similar articles

See all similar articles

Cited by 1 PubMed Central articles

Publication types

MeSH terms

Feedback